Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Pradaxa Wrongful Death Lawsuit May Proceed to Trial After Summary Judgment Denied October 20, 2016 Austin Kirk Add Your Comments A federal judge has rejected a motion for summary judgment filed by Boehringer Ingelheim, in what is expected to be the first case to go to trial over the side effects of Pradaxa, which allegedly caused the bleeding death of a Massachusetts doctor. A wrongful death lawsuit filed by the family of Dr. Zhensheng Liu is set to be ready for trial to begin in the U.S. District Court for the District of Massachusetts by December 5, after Boehringer Ingelheim failed to resolve the case as part of a $650 million agreement reached in 2014, which settled thousands of similar Pradaxa lawsuits. At one time, Boehringer Ingelheim faced more than 4,000 product liability lawsuits alleging that individuals suffered severe and fatal bleeding events while using their new-generation anticoagulant Pradaxa (dabigatran), which was introduced in October 2010 as a superior alternative to warfarin. Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION While the decades-old anticoagulant warfarin has a known and effective reversal agent, allowing doctors to control and stop bleeds that may occur during use, Pradaxa was introduced without an approved antidote, leaving many doctors helpless to treat bleeding patients who were prescribed the new anticoagulant. The lawsuit filed by Dr. Liu’s family and other plaintiffs presented claims alleging that Boehinger Ingelheim failed to adequately warn consumers or the medical community about the bleeding risk and lack of a reversal agent, as well as claims for negligent design defect and negligent testing of Pradaxa. Following several years of consolidated proceedings in a federal multidistrict litigation (MDL), Boehringer Ingelheim reached a Pradaxa settlement agreement that resolved most cases in 2014. However, the Pradaxa wrongful death lawsuit filed by Dr. Liu’s children was not settled, and the case was one of the first remanded back to the district court where it was originally filed for an individual trial date. During a scheduling conference shortly after the case was transferred back to the District of Massachusetts, U.S. District Judge William Young ordered that the case be ready for trial to begin the first week of December 2016. However, Boehinger Ingelheim filed a motion for summary judgment, seeking to dismiss the claims before it reached a jury. In an order (PDF) issued this week, Judge Young granted the motion to dismiss claims involving negligent design defects and negligent testing of Pradaxa, but rejected the request to dismiss the primary claims for negligent failure to warn. As a result, the case remains on track to be the first Pradaxa trial to go before a jury in the United States. The case presents a factual pattern similar to what has been experienced by other users of the Pradaxa and similar new-generation anticoagulants, indicating that Dr. Liu died in 2012, after experiencing a fatal brain bleed allegedly caused by the atrial fibrillation anticoagulant. While entering his car on Thanksgiving day, Dr. Liu suffered what his family describes as a “modest fall and head injury.” However, Dr. Liu experienced an uncontrollable brain bleed that ultimately resulted in his death days later, due to the lack of a safe and effective reversal agent. Since the drug hit the market in October 2010, as the first member of a new class of anticoagulants known as factor XA inhibitors, a large number of Pradaxa bleeding problems began to emerge, where doctors indicated that they were unable to stop or reverse hemorrhaging or other bleeds. Similar issues have also been seen with other members of this new generation of drugs, which also include the blockbuster medications Xarelto (rivaroxaban) and Eliquis (apixaban). While most lawsuits over Pradaxa have been resolved, the Liu trial will be closely watched, as thousands of Xarelto lawsuits and Eliquis lawsuits are still pending nationwide. Tags: Blood Thinner, Boehringer Ingelheim, Brain Hemorrhage, Pradaxa, Wrongful Death Lawsuit Image Credit: | More Pradaxa Lawsuit Stories Jury Awards $540K in Pradaxa Trial Against Boehringer Ingelheim May 21, 2019 Paragard IUD Lawsuit Dismissed on Summary Judgment February 25, 2019 Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: yesterday) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025) Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 4 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025) Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (Posted: 5 days ago) The withdrawal of two Cartiva toe implant lawsuits has sparked rumors of a potential settlement agreement to resolve product liability claims over the recalled devices. MORE ABOUT: CARTIVA IMPLANT LAWSUITFailed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)
Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: yesterday) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 4 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025)
Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (Posted: 5 days ago) The withdrawal of two Cartiva toe implant lawsuits has sparked rumors of a potential settlement agreement to resolve product liability claims over the recalled devices. MORE ABOUT: CARTIVA IMPLANT LAWSUITFailed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)